Atara Biotherapeutics' Series B - II Round

Atara Biotherapeutics raised a round of funding on January 10, 2014.

Atara Biotherapeutics is a privately-held drug development company with a focus on innovative therapies for patients with debilitating diseases. The research of Atara and its family of companies is ba…

Articles about Atara Biotherapeutics' Series B - II Round: